MENU
+Compare
TXMD
Stock ticker: NASDAQ
AS OF
Apr 23, 04:58 PM (EDT)
Price
$1.07
Change
-$0.04 (-3.60%)
Capitalization
24.32M

TXMD TherapeuticsMD Forecast, Technical & Fundamental Analysis

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories... Show more

TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TXMD with price predictions
Apr 22, 2025

TXMD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for TXMD turned positive on April 11, 2025. Looking at past instances where TXMD's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on TXMD as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

TXMD moved above its 50-day moving average on April 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TXMD crossed bullishly above the 50-day moving average on April 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TXMD advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TXMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TXMD broke above its upper Bollinger Band on April 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TXMD entered a downward trend on March 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.867) is normal, around the industry mean (61.171). P/E Ratio (0.474) is within average values for comparable stocks, (90.174). TXMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.344) is also within normal values, averaging (20.123).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TXMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TXMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TXMD is expected to report earnings to fall 180.00% to 3 cents per share on March 31

TherapeuticsMD TXMD Stock Earnings Reports
Q4'24
Est.
$0.04
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.12
Q1'24
Missed
by $0.10
Q4'23
Est.
$-0.13
The last earnings report on November 12 showed earnings per share of -5 cents, missing the estimate of 3 cents. With 54.81K shares outstanding, the current market capitalization sits at 24.32M.
A.I. Advisor
published General Information

General Information

a specialty pharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
951 Yamato Road
Phone
+1 561 961-1900
Employees
417
Web
https://www.therapeuticsmd.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAB1.270.08
+6.72%
Standard BioTools
WGS96.895.85
+6.43%
GeneDx Holdings Corp
DB24.331.06
+4.56%
Deutsche Bank Aktiengesellschaft
FOUR77.002.07
+2.76%
Shift4 Payments
BTM1.31-0.07
-5.07%
Bitcoin Depot

TXMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TXMD has been loosely correlated with LIEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TXMD jumps, then LIEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXMD
1D Price
Change %
TXMD100%
+11.42%
LIEN - TXMD
36%
Loosely correlated
+1.78%
DRRX - TXMD
32%
Poorly correlated
-0.93%
SCYX - TXMD
30%
Poorly correlated
+2.65%
ASRT - TXMD
27%
Poorly correlated
-0.99%
ACB - TXMD
23%
Poorly correlated
+1.43%
More